Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-11-28
2009-11-03
Anderson, Rebecca L (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S397000, C514S413000, C514S414000, C514S415000, C546S277400, C548S312100, C548S455000, C548S465000
Reexamination Certificate
active
07612099
ABSTRACT:
The invention is concerned with vinylogous acids derivatives of formula (I)wherein A and R1to R6are as defined in the description and in the claims, as well as physiologically acceptable salts thereof. These compounds inhibit chymase and can be used as medicaments.
REFERENCES:
patent: 4443615 (1984-04-01), Matsuoka et al.
patent: 5436264 (1995-07-01), Pfister et al.
patent: 6432978 (2002-08-01), Tani et al.
patent: 6852734 (2005-02-01), Yamamoto et al.
patent: 2005/0119329 (2005-06-01), Godel et al.
patent: 1284266 (1993-02-01), None
patent: 701988 (1996-03-01), None
patent: 945443 (1999-09-01), None
patent: 1136488 (2001-09-01), None
patent: 05078250 (1993-03-01), None
patent: WO 8200032 (1982-02-01), None
patent: WO 93/23040 (1993-11-01), None
patent: WO 93/23041 (1993-11-01), None
patent: WO 00/35452 (2000-06-01), None
patent: WO 03016307 (2003-02-01), None
patent: WO 2004/082687 (2004-09-01), None
patent: WO 2005/009993 (2005-02-01), None
Doggrell et al., Can. J. Physiol. Pharmacol., 83, pp. 123-130 (2005).
Lindstedt et al., Curr. Opin. Lipidol, 15, pp. 567-573 (2004).
Reed et al., J. Allergy Clin. Immunol., 114, pp. 997-1008 (2004).
Takai et al., Eur. J. Pharmacol, 501, pp. 1-8 (2004).
Takai etal., Trends Pharmacol Sci., 25(10), pp. 518-522 (2004).
Miyata et al., Angew. Chem., 94(8), pp. 651-652 (1982).
Hofheinz et al., Helvetica Chimica Acta, 60(2), pp. 660-669 (1977).
Galeotti et al., J. Org. Chem., 58, pp. 5370-5376 (1993).
Krepski et al., Tetrahedron Letters, 26(8), pp. 981-984 (1985).
Compain et al., Synlett, 11, pp. 943-945 (1994).
Nguyen et al., J. Am. Chem. Soc., 125, pp. 11818-11819 (2003).
Hamer, N.K., Tetrahedron Letters, 27(19), pp. 2167-2168 (1986).
Matsuo et al., Chem. Pharm. Bull., 32(9), pp. 3724-3729 (1984).
Mizuno et al., Chem. Pharm. Bull., 23(3), pp. 527-537 (1975).
Ho et al., J. Medicinal Chemistry, 14(6), pp. 553-554 (1971).
Hasegawa et al., Heterocycles, 51(12), pp. 2815-2821 (1999).
Contour-Galcéra et al., Bioorganic & Medicinal Chemistry Letters, 15, pp. 3555-3559 (2005).
Khalil et al., Journal of Biological Chemistry, 273(46), pp. 30321-30327(1998).
Nenajdenko et al., Tetrahedron, 60, pp. 11719-11724 (2004).
Cheve et al., Med. Chem. Res., 11(7), pp. 361-379 (2003).
Mor et al., J. Med. Chem., 41, pp. 3831-3844 (1998).
Heath-Brown et al., J. Chem. Soc., Abstracts, pp. 7165-7178 (1965).
Nagarathnam et al., Synthetic Communications, 23(14), pp. 2011-2017 (1993).
Hengartner et al., J. Org. Chem., 44(22), pp. 3741-3747 (1979).
Yang et al., Indian Journal of Chemistry, 38B(8), pp. 897-904 (1999).
Tani, M. et al,Jour. of Antibiotics,57(2) 89-96 (2004) XP002419474.
Tani, M. et al,Jour. of Antibiotics,57(2) 83-88 (2004) XP002419475.
Banner David
Hilpert Hans
Kuhn Bernd
Mauser Harald
Anderson Rebecca L
Hoffmann-La Roche Inc.
Johnston George W.
Nolan Jason
Remy Brian C.
LandOfFree
Vinylogous acid derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Vinylogous acid derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Vinylogous acid derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4090453